Palantir Posts First Quarterly Profit Following New Contract Wins
- Uncategorized
- February 14, 2023
As Delhi’s air quality continues to worsen, the demand for respiratory drugs has surged, with Foracort emerging as India’s best-selling medicine in October. The inhaler, used to treat asthma and chronic obstructive pulmonary disease (COPD), achieved Rs 75 crore in sales, surpassing well-known medications like the antibiotic Augmentin (Rs 73 crore) and the antidiabetic Glycomet-GP
READ MORE